Dr. Gonsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
451 Clarkson Ave Building A FL 7
Kings County Hospital Center
Brooklyn, NY 11203Phone+1 718-245-2770Fax+1 718-245-3808
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2001 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
- NY State Medical License 2005 - 2025
- IL State Medical License 2001 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 19 citationsThrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.David J. Araten, Rosario Notaro, Howard T. Thaler, Nancy A. Kernan, Farid Boulad
Haematologica. 2012-03-01 - 50 citationsMogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphomaAdrienne A. Phillips, Paul Fields, Olivier Hermine, Juan Carlos Ramos, Brady E Beltran
Haematologica. 2019-05-01 - 7 citationsMacrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells.Danielle F Joseph, Jason Gonsky, Stacy W. Blain
Plos One. 2018-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: